Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

When examining the prices of new medicines, the question of how much the private and public sectors have contributed to their R&D is often raised. Contributions can be assessed in terms of the investment, authorship of publications, marketing authorizations and intellectual property rights associated with biopharmaceutical R&D. This review of the empirical evidence underlines the complementary and interwoven nature of the private and public sectors in supporting biopharmaceutical R&D. Both sectors invest in and contribute to biopharmaceutical R&D, with the public sector predominantly focusing on basic research and the private sector mainly targeting medicine discovery and development. Public-sector investment generates additional private-sector investment. Copyright © 2021 Elsevier Ltd. All rights reserved.


Steven Simoens, Isabelle Huys. How much do the public sector and the private sector contribute to biopharmaceutical R&D? Drug discovery today. 2022 Apr;27(4):939-945

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 34863932

View Full Text